Angelique Cercillieux

A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor

Judith Giroud‐Gerbetant, Magali Joffraud, Maria Pilar Giner et al. · Molecular Metabolism · 2019 · 134 citations · Full text

Life Sciences, Biochemistry, Pharmacology +13

Evaluation of the Toxicity of Intravitreally Injected PLGA Microspheres and Rods in Monkeys and Rabbits: Effects of Depot Size on Inflammatory Response

Evan A. Thackaberry, Cindy Farman, Fiona Zhong et al. · Investigative Ophthalmology & Visual Science · 2017 · 79 citations · Full text

Pharmacy, Ophthalmology, Pharmaceutics +17

Crosstalk between Drp1 phosphorylation sites during mitochondrial remodeling and their impact on metabolic adaptation

Miriam Valera‐Alberni, Magali Joffraud, Joan Miró et al. · Cell Reports · 2021 · 57 citations · Full text

Life Sciences, Biochemistry, Physiology +17

Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage

Audrey Sambeat, Joanna Ratajczak, Magali Joffraud et al. · Nature Communications · 2019 · 53 citations · Full text

Life Sciences, Biochemistry, Physiology +17

Mutagenic Potential of DNA Glycation: Miscoding by (<i>R</i>)- and (<i>S</i>)-<i>N</i>²-(1-Carboxyethyl)-2′-deoxyguanosine

Gerald E. Wuenschell, Daniel Tamae, Angelique Cercillieux et al. · Biochemistry · 2010 · 45 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15